These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 7215739)

  • 21. [Indications for trimethoprim in otorhinolaryngology].
    Chüden HG
    Med Klin; 1972 Feb; 67(5):167-70. PubMed ID: 5014141
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of a new sulfa-trimethoprim combination (trimethoprim-sulfamethopyrazine) in typhoid fever. A double-blind study on 72 adult patients.
    Schiraldi O; Sforza E; Piaia F
    Chemotherapy; 1985; 31(1):68-75. PubMed ID: 3882355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trimethoprim-sulfamethoxazole in the treatment of infections of the ears, nose, and throat.
    Quick CA; Wagner D
    J Infect Dis; 1973 Nov; 128():Suppl:696-700. PubMed ID: 4202209
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical assessment of a trimethoprim-sulfamethopyrazine combination (Kelfiprim) in lower respiratory tract infections.
    Harazim H; John M; Pandelitschka E; Bröll H; Jackwerth G
    J Int Med Res; 1983; 11(4):197-204. PubMed ID: 6352364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of otorhinolaryngological infections with minocycline].
    Sanbe B; Murakami H; Takeuchi M; Nishizaki K; Jo K
    Jpn J Antibiot; 1969 Dec; 22(6):507-10. PubMed ID: 5309769
    [No Abstract]   [Full Text] [Related]  

  • 26. [Eusaprim-equivalent to broad spectrum antibiotics].
    Heynen U
    Z Allgemeinmed; 1971 Oct; 47(30):1600-2. PubMed ID: 4256924
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term oral treatment of urinary tract infections with single daily doses of a new antibacterial drug combination (Kelfiprim).
    von Niederhäusern W; Boillat JJ; Petrescu D; Groppi W; Fanfani A; Mandelli V
    Urol Res; 1983; 11(4):181-5. PubMed ID: 6359636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kelfiprim, a new sulpha-trimethoprim combination, versus cotrimoxazole, in the treatment of urinary tract infections: a multicentre, double-blind trial.
    Pisani E; Pavone-Macaluso M; Rocco F; Piaia F; Pirozzi F; Rotolo U; Lamartina M; Melloni D; Larcker P
    Urol Res; 1982 Feb; 10(1):41-4. PubMed ID: 7041395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies of the therapeutic effectivenss of a drug association with delayed action in acute and chronic rhinitis and sinusitis and in other otorhinolaryngological diseases].
    Pallestrini EA
    Minerva Otorinolaringol; 1968; 18(6):315-29. PubMed ID: 5745687
    [No Abstract]   [Full Text] [Related]  

  • 30. [Continuous treatment with trimethoprim-sulfamethoxypyrazine of immunocompromised patients].
    González B; Boldrini G
    Rev Chil Pediatr; 1987; 58(6):449-54. PubMed ID: 3506213
    [No Abstract]   [Full Text] [Related]  

  • 31. Trimet v amoxycillin in the treatment of otitis media in children.
    Godfrey AA; Keenan TD; Summerfield M
    N Z Med J; 1985 Apr; 98(776):252. PubMed ID: 3857506
    [No Abstract]   [Full Text] [Related]  

  • 32. [Chlormethylencycline in otorhinolaryngologic diseases. (Clinical trials)].
    Di Brino M; Baldiserri L
    Atti Accad Fisiocrit Siena Med Fis; 1967; 16(1):329-41. PubMed ID: 5621897
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical efficacy of ofloxacin in the treatment of otorhinolaryngological infections.
    Baba S
    Infection; 1986; 14 Suppl 4():S327-31. PubMed ID: 3546157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comments on current antibiotic therapy.
    Winterbauer RH
    Otolaryngol Clin North Am; 1979 May; 12(2):431-8. PubMed ID: 460882
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results obtained with the combination of trimethoprim (2,4-diamino-3[3,4,5]-pyrimidine) and sulfamethoxazole (5-methyl-3-sulfanylamidoxazole) in the treatment of acute infections of otorhinolaryngologic import].
    Ariano M
    Otorinolaringol Ital; 1973; 39(3):203-6. PubMed ID: 4536452
    [No Abstract]   [Full Text] [Related]  

  • 36. [Interaction of sulfamethoxypirazine-Trimethoprim on schizomycetes in vitro].
    Schioppacassi G; Mandelli V; Mazzoleni R; Morvillo E
    G Ital Chemioter; 1979; 26(1-2):181-8. PubMed ID: 122076
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical use of midecamycin. Apropos of 60 cases].
    Ghanassia JP; Domart A
    G Ital Chemioter; 1977; 24(1-2):63-5. PubMed ID: 615764
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative effectiveness of treatment of acute pneumonia with various antibacterial preparations].
    Umakhanova ZhSh; Emirbekova FN
    Ter Arkh; 1980; 52(3):80-3. PubMed ID: 6966838
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical trial of the antibacterial combination sulfamoxole/trimethoprim (CN 3123)/Third communication: Clinical results of a field trial with CN 3123 in bronchopulmonary and ENT (ear/nose/throat) infections (author's transl)].
    Etzel M; Neuhof F; Wesenberg W
    Arzneimittelforschung; 1976; 26(42):671-3. PubMed ID: 782475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kelfiprim versus co-trimoxazole in recurrent and persistent urinary tract infections: multicenter double-blind trial.
    Graziani G; Chiarini C; Limido D; Cantaluppi A; Marai P; Pincella G; Piaia F; Zucchelli P; Locatelli F; Ponticelli C
    Urology; 1987 Sep; 30(3):293-7. PubMed ID: 3307097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.